Skip Navigation

Cardiovascular Research 2004 62(3):509-520; doi:10.1016/j.cardiores.2004.01.029
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sun, H.
Right arrow Articles by Backx, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, H.
Right arrow Articles by Backx, P. H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

The phosphoinositide 3-kinase inhibitor LY294002 enhances cardiac myocyte contractility via a direct inhibition of Ik,slow currents

Hui Sun, Gavin Y. Oudit, Rafael J. Ramirez, Danny Costantini and Peter H. Backx*

Department of Physiology and Medicine, Heart & Stroke/Richard Lewar Centre and Division of Cardiology, University Health Network, University of Toronto Fitzgerald Building, 150 College St., Toronto, Ontario, Canada M5S 3E2

* Corresponding author. Tel.: +1-416-946-8112, +1-416-528-4003; fax: +1-416-946-8380. Email address: p.backx{at}utoronto.ca

Objective: Phosphoinositide 3-kinase (PI3K) is a key component in regulating myocardial growth, survival and contractility. LY294002 and wortmannin are two PI3K inhibitors used widely to establish the role of PI3K. The goal of this study was to examine the effects of acute application of LY294002 and wortmannin on cardiac myocyte contractility and underlying machanisms. Methods: Patch-clamp, indo-1 epifluorescence and video-edge detection techniques were used to measure outward K+ currents, action potentials (AP), Ca2+ transients and shortening of myocytes isolated from mouse left ventricular free wall. Results: In field-stimulated myocytes, LY294002 (10 µmol/l) increased Ca2+ transient amplitude by 23%, and cell shortening amplitude by 60% in the absence or presence of wortmannin, while wortmannin alone had no effect. LY294002 (but not wortmannin) prolonged AP duration by specifically inhibiting slowly inactivating K+ currents (i.e., the 4-aminopyrydine-sensitive Ik,slow1 and the tetraethylammonium-sensitive Ik,slow2), leading to an increase in sarcoplasmic reticular Ca2+ levels. It appeared that the AP prolongation was responsible for elevated contractility since AP-clamp of myocytes with prolonged APs (recorded in LY294002-treated myocytes) induced a 29% increase in cell shortening compared with control APs, while LY294002 application did not increase contractility in voltage-clamp studies using either step or AP depolarizations. Conclusions: The putative PI3K inhibitor LY294002 increases Ca2+ release and myocyte contractility via direct inhibition of cardiac Ik,slow and AP prolongation, thus limiting the usefulness of this agent in the analyses of the role of PI3K in heart function.

KEYWORDS Phosphoinositide 3-kinase; LY294002; Cardiac myocyte contractility; Ca2+ transient; Action potential; Ik,slow currents


Time for primary review 25 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
Y.-G. Sun, Y.-X. Cao, W.-W. Wang, S.-F. Ma, T. Yao, and Y.-C. Zhu
Hydrogen sulphide is an inhibitor of L-type calcium channels and mechanical contraction in rat cardiomyocytes
Cardiovasc Res, June 17, 2008; (2008) cvn140v2.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.